Anlon Healthcare (NSE:AHCL) Other Stockholders Equity: ₹1,771 Mil (As of Mar. 2026)


NSE:AHCL Anlon Healthcare Ltd NSE:AHCL
17 GF Score
Price ₹15.59
! 5 Warning Signs
View Full Analysis

What is Anlon Healthcare Other Stockholders Equity?

Anlon Healthcare NSE:AHCL +0.78% 17 Other Stockholders Equity is ₹1,771 Mil as of Mar. 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 17/100. The stock has 5 warning signs investors should review.

Anlon Healthcare's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ₹1,771 Mil.

Anlon Healthcare's quarterly Other Stockholders Equity declined from Sep. 2025 (₹1,612 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,771 Mil).

Anlon Healthcare's annual Other Stockholders Equity increased from Mar. 2024 (₹-0 Mil) to Mar. 2025 (₹0 Mil) and increased from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹1,771 Mil).

Anlon Healthcare Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Anlon Healthcare's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anlon Healthcare Other Stockholders Equity Chart

Anlon Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
-0.00 0.00 -0.00 0.00 1,770.77

Anlon Healthcare Quarterly Data
Mar22 Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1,611.64 0.00 1,770.77
NSE:AHCL
17GF Score
Anlon Healthcare Ltd NSE:AHCL
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anlon Healthcare Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹1,771 Mil mean?
Anlon Healthcare (NSE:AHCL) has a Other Stockholders Equity of ₹1,771 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Anlon Healthcare and its competitors.
Is Anlon Healthcare's Other Stockholders Equity too high?
Anlon Healthcare's current Other Stockholders Equity is ₹1,771 Mil. Overall, Anlon Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Other Stockholders Equity compare to ZTS and UTHR?
Anlon Healthcare's Other Stockholders Equity of ₹1,771 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Anlon Healthcare and its competitors. Anlon Healthcare's current Other Stockholders Equity is ₹1,771 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Other Stockholders Equity of ₹1,771 Mil. The current Other Stockholders Equity is ₹1,771 Mil. Anlon Healthcare's overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Other Stockholders Equity is ₹1,771 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anlon Healthcare Business Description

Other Exchanges 544497:India
Address Kalawad Road, 101/102, Silvercoin Complex, Opposite Crystal Mall, Rajkot, GJ, IND, 360 005
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
17GF Score

Get the complete analysis for NSE:AHCL

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.59
Price